Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Baatje MS"'
Autor:
Nobre RJ; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; ViraVector-Viral Vector for Gene Transfer Core Facility and University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research (III), University of Coimbra, Coimbra, Portugal., Lobo DD; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research (III), University of Coimbra, Coimbra, Portugal., Henriques C; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; ViraVector-Viral Vector for Gene Transfer Core Facility and University of Coimbra, Coimbra, Portugal.; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., Duarte SP; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research (III), University of Coimbra, Coimbra, Portugal., Lopes SM; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research (III), University of Coimbra, Coimbra, Portugal., Silva AC; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research (III), University of Coimbra, Coimbra, Portugal., Lopes MM; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research (III), University of Coimbra, Coimbra, Portugal., Mariet F; uniQure Biopharma b.v., Amsterdam, The Netherlands., Schwarz LK; uniQure Biopharma b.v., Amsterdam, The Netherlands., Baatje MS; uniQure Biopharma b.v., Amsterdam, The Netherlands., Ferreira V; uniQure Biopharma b.v., Amsterdam, The Netherlands., Vallès A; uniQure Biopharma b.v., Amsterdam, The Netherlands., Pereira de Almeida L; Center for Neuroscience and Cell Biology (CNC), Molecular Therapy of Brain Disorders Group, University of Coimbra, Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, Coimbra, Portugal.; ViraVector-Viral Vector for Gene Transfer Core Facility and University of Coimbra, Coimbra, Portugal.; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., Evers MM; uniQure Biopharma b.v., Amsterdam, The Netherlands., Toonen LJA; uniQure Biopharma b.v., Amsterdam, The Netherlands.
Publikováno v:
Nucleic acid therapeutics [Nucleic Acid Ther] 2022 Jun; Vol. 32 (3), pp. 194-205. Date of Electronic Publication: 2021 Dec 07.
Autor:
Pietersz KL; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands.; Department of Molecular Animal Physiology, Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, Faculty of Science, Radboud University, Nijmegen, the Netherlands., Martier RM; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Baatje MS; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands., Liefhebber JM; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands., Brouwers CC; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands., Pouw SM; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands., Fokkert L; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands., Lubelski J; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands., Petry H; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands., Martens GJM; Department of Molecular Animal Physiology, Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, Faculty of Science, Radboud University, Nijmegen, the Netherlands., van Deventer SJ; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Konstantinova P; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands. P.konstantinova@uniqure.com., Blits B; Department of Research & Development, uniQure biopharma B.V., Amsterdam, the Netherlands.; Blits Biopharma Consultancy and DegenRx BV, Amsterdam, the Netherlands.
Publikováno v:
Gene therapy [Gene Ther] 2021 Aug; Vol. 28 (7-8), pp. 435-446. Date of Electronic Publication: 2020 Aug 15.